Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
8.81
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
9.08
+0.27 (3.06%)
After-hours: Dec 5, 2025, 7:01 PM EST
Corvus Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 658 | 344 | 86 | 40 | 112 | 100 | |
| Market Cap Growth | 22.77% | 298.31% | 118.11% | -64.73% | 12.29% | -37.55% | |
| Enterprise Value | 593 | 302 | 56 | -7 | 40 | 51 | |
| Last Close Price | 8.81 | 5.35 | 1.76 | 0.85 | 2.41 | 3.56 | |
| PB Ratio | 9.17 | 10.56 | 2.23 | 0.71 | 1.16 | 1.39 | |
| P/TBV Ratio | 9.17 | 10.56 | 2.23 | 0.71 | 1.16 | 1.39 | |
| Debt / Equity Ratio | 0.01 | 0.03 | 0.04 | 0.05 | 0.04 | 0.03 | |
| Quick Ratio | 8.18 | 1.47 | 3.96 | 3.99 | 7.22 | 3.65 | |
| Current Ratio | 8.29 | 1.54 | 4.07 | 4.06 | 7.36 | 3.73 | |
| Return on Equity (ROE) | -35.82% | -174.85% | -57.02% | -53.90% | -51.08% | -8.37% | |
| Return on Assets (ROA) | -34.87% | -30.09% | -25.63% | -22.50% | -24.61% | -32.33% | |
| Return on Capital (ROIC) | -56.78% | -46.69% | -29.52% | -25.06% | -27.38% | -36.77% | |
| Return on Capital Employed (ROCE) | -53.70% | -82.20% | -60.30% | -55.60% | -38.50% | -59.60% | |
| Earnings Yield | -2.29% | -18.12% | -31.32% | -104.39% | -38.55% | -6.00% | |
| FCF Yield | -4.90% | -7.40% | -27.77% | -68.97% | -32.73% | -34.89% | |
| Buyback Yield / Dilution | -34.14% | -26.99% | -3.16% | -11.23% | -41.98% | -0.44% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.